Oxyrane (AgeTech UK) Biomed

Central nervous system diseases, enzyme replacement therapies, lysosomal storage diseases. Oxyrane develops enhanced enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases, with a focus on the diseases of the central nervous system.
Technology: AgeTech Companies
Industry: UK AgeTech 2020
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership